| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
35 Abnormal chromatin clumping in leucocytes syndrome with a high fraction of bone marrow cells in S-phase and In vitro autonomous growth
|
Valleio, C
|
|
1997
|
21 |
1S1 |
p. S9
|
artikel
|
| 2 |
107 Abnormal motility patterns of neutrophils in myelodysplastic syndromes identified by image analysis
|
Azzarà, A
|
|
1997
|
21 |
1S1 |
p. S28
|
artikel
|
| 3 |
132 A case of a t(1;3)(p36:q21) in chronic myelomonocytic leukemia with thrombocytosis and TPO gene expression in malignant cells
|
Ciolli, S.
|
|
1997
|
21 |
1S1 |
p. S34
|
artikel
|
| 4 |
169 Aggressive chemotherapy in MDS: The Düsseldorf experience
|
Aul, C.
|
|
1997
|
21 |
1S1 |
p. S45
|
artikel
|
| 5 |
196 Allogeneic bone marrow transplantation for adults with primary myelodysplastic syndrome: Evaluation of prognostic factors
|
Shepherd, JD
|
|
1997
|
21 |
1S1 |
p. S52
|
artikel
|
| 6 |
163 Amifostine in low-risk and combined therapy with gemcitabine in high-risk myelodysplastic syndromes
|
Sezer, O.
|
|
1997
|
21 |
1S1 |
p. S42
|
artikel
|
| 7 |
36 AML post RAEB with intense granulation alterations
|
Rozman, M.
|
|
1997
|
21 |
1S1 |
p. S10
|
artikel
|
| 8 |
51 Analysis of prognostic factors for low risk myelodysplastic syndrome; a proposal of new scoring system
|
Tomonaga, M.
|
|
1997
|
21 |
1S1 |
p. S14
|
artikel
|
| 9 |
170 Anti-AML chemotherapy in high-risk MDS: The M.D. Anderson cancer center experience
|
Estey, E.
|
|
1997
|
21 |
1S1 |
p. S45
|
artikel
|
| 10 |
79 Antigenic characterization of bone marrow endosteal cells: A stem cell hypothesis reevaluated
|
Walchshofer, S.
|
|
1997
|
21 |
1S1 |
p. S21
|
artikel
|
| 11 |
151 A patient-oriented approach to the use of erythropoietin in myelodysplastic syndromes
|
Cazzola, Mario
|
|
1997
|
21 |
1S1 |
p. S39
|
artikel
|
| 12 |
101 Apoptosis and fas antigen (CD95) expression in myclodysplasia
|
Bouscary, D.
|
|
1997
|
21 |
1S1 |
p. S26
|
artikel
|
| 13 |
21 Association between myelodysplastic syndromes and inflammatory bowel diseases: report of 4 new cases and review of previously reported cases
|
Wattel, E
|
|
1997
|
21 |
1S1 |
p. S6
|
artikel
|
| 14 |
40 Atypical sweet's syndrome (SS) in a patient with AML secondary to a RAEB-T
|
Pagano, L.
|
|
1997
|
21 |
1S1 |
p. S11
|
artikel
|
| 15 |
34 Atypical variants of MDS in children
|
Torubarova, N.
|
|
1997
|
21 |
1S1 |
p. S9
|
artikel
|
| 16 |
Author index
|
|
|
1997
|
21 |
1S1 |
p. I-VIII
|
artikel
|
| 17 |
195 Autologous bone marrow (ABMT) or peripheral blood stem cell (ABSCT) transplantation after intensive chemotherapy in myelodysplastic syndromes (MDS)
|
Wartel, E.
|
|
1997
|
21 |
1S1 |
p. S52
|
artikel
|
| 18 |
9 Benzene exposure and risk of MDS/AML
|
Smith, M.T.
|
|
1997
|
21 |
1S1 |
p. S3
|
artikel
|
| 19 |
77 Biological consequences of stromal abnormalities in the myelodysplastic syndrome (MDS): Its influence on the hematopoietic dysregulation
|
Silverman, L.R.
|
|
1997
|
21 |
1S1 |
p. S20
|
artikel
|
| 20 |
193 BMT in MDS: The experience of the EBMT
|
Boogaerts, Marc A.
|
|
1997
|
21 |
1S1 |
p. S51
|
artikel
|
| 21 |
90 Bone marrow culture studies in myelodysplastic syndromes
|
de Souza Femandez, Teresa
|
|
1997
|
21 |
1S1 |
p. S24
|
artikel
|
| 22 |
192 Bone marrow transplantation for myelodysplasia: The IBMTR data
|
Sierra, J.
|
|
1997
|
21 |
1S1 |
p. S51
|
artikel
|
| 23 |
200 Bone marrow transplantation in patients with myelodysplastic syndrome. A single center experience
|
Cermak, J.
|
|
1997
|
21 |
1S1 |
p. S53
|
artikel
|
| 24 |
127 Both inhaled and ingested substances are involved in secondary myelodysplastic syndromes (MDS) with 6p changes
|
Ciolli, S.
|
|
1997
|
21 |
1S1 |
p. S33
|
artikel
|
| 25 |
202 Calcitriol in the treatment of myelodysplastic syndromes
|
Mellibovsky, L.
|
|
1997
|
21 |
1S1 |
p. S55
|
artikel
|
| 26 |
177 Carboplatin(CBDCA) alone or in combination in the treatment of acute myeloid leukema (AML) secondary to myelodysplastic syndromes and in other high risk AML
|
Larrea, L.
|
|
1997
|
21 |
1S1 |
p. S47
|
artikel
|
| 27 |
102 CD34+ cells in myelodisplastic syndromes with lower percent of blasts are characterized by high spontaneus rate of apoptosis
|
Ricciardi, M.R.
|
|
1997
|
21 |
1S1 |
p. S27
|
artikel
|
| 28 |
61 CFU-GM growth and survival in 258 patients with myelodysplastic syndromes
|
Jelínek, J.
|
|
1997
|
21 |
1S1 |
p. S16
|
artikel
|
| 29 |
172 Chemotherapy of adult chronic myelomonocytic leukemia (CMML)
|
Wattel, E.
|
|
1997
|
21 |
1S1 |
p. S46
|
artikel
|
| 30 |
188 Chemotherapy-related infections in myelodysplastic syndromes (MDS) and acute myeloid leukemia secondary to MDS (sAML). A study of 27 patients
|
Jarque, I.
|
|
1997
|
21 |
1S1 |
p. S50
|
artikel
|
| 31 |
119 Childhood myelodysplasia: Cytogenetic and fish studies
|
Mancini, M.
|
|
1997
|
21 |
1S1 |
p. S31
|
artikel
|
| 32 |
58 Chromosomal abnormalities in patients with myelodysplastic syndromes of low and high cytologic risk
|
Rus, G. Pérez
|
|
1997
|
21 |
1S1 |
p. S16
|
artikel
|
| 33 |
112 Chromosomal abnormalities in secondary MDS/AML relationships to prior drugs and radiation
|
Pedersen-Bjergaard, Jens
|
|
1997
|
21 |
1S1 |
p. S29
|
artikel
|
| 34 |
122 Chromosome 5Q31-specific DNA probe to detect intertitial long arm deletions of chromosome
|
Bernasconi, P.
|
|
1997
|
21 |
1S1 |
p. S32
|
artikel
|
| 35 |
30 Chronic myelomonocytic leukemia as a secondary myelodysplasia in a chronic lymphoid leukemia case
|
Brunel, V
|
|
1997
|
21 |
1S1 |
p. S8
|
artikel
|
| 36 |
28 Chronic myelomonocytic leukemia: Clinical and hematopathological features of 27 patients
|
Marisavljevic, D.
|
|
1997
|
21 |
1S1 |
p. S8
|
artikel
|
| 37 |
181 Cladribine (2-CDA) is active in “high-risk”-chronic myelomonocytic leukemia and secondary or relapsed acute myelo(Mono)cytic leukemia
|
Krieger, O.
|
|
1997
|
21 |
1S1 |
p. S48
|
artikel
|
| 38 |
31 Classification of chronic neutrophilic leukemia: — A report of 2 patients and review of 73 cases from the literature
|
Ben-Tal, O.
|
|
1997
|
21 |
1S1 |
p. S8
|
artikel
|
| 39 |
24 Clinical and biological profile of 55 patients with Refractory Anemia with Ring Sideroblasts
|
Richart, A.
|
|
1997
|
21 |
1S1 |
p. S7
|
artikel
|
| 40 |
137 Clinical potential of mutant ras
|
Mufti, Ghulam J.
|
|
1997
|
21 |
1S1 |
p. S35
|
artikel
|
| 41 |
152 Clinical results of the use of different cytokines in MDS
|
Hellström-Lindberg, Eva
|
|
1997
|
21 |
1S1 |
p. S39
|
artikel
|
| 42 |
120 Clonal evolution in myelodysplasic syndromes
|
Rus, G. Pérez
|
|
1997
|
21 |
1S1 |
p. S31
|
artikel
|
| 43 |
71 Clonality of hematopoiesis in myelodysplasia
|
Willemze, R.
|
|
1997
|
21 |
1S1 |
p. S19
|
artikel
|
| 44 |
125 Clonal karyotypic abnormalities after autologous transplantation (AT)
|
Amigo, M.L.
|
|
1997
|
21 |
1S1 |
p. S32
|
artikel
|
| 45 |
2 Codification of dysmyelopoiesis in myelodysplastic syndromes
|
Flandrin, Georges
|
|
1997
|
21 |
1S1 |
p. S1
|
artikel
|
| 46 |
7 Combined morphological, immunological and cytogenetic techniques in the diagnosis of myelodysplastic syndromes (MDS)
|
Woessner, S.
|
|
1997
|
21 |
1S1 |
p. S2
|
artikel
|
| 47 |
50 Correlation of karyotype with clinical features and prognosis in 349 patients with MDS
|
Haase, D.
|
|
1997
|
21 |
1S1 |
p. S14
|
artikel
|
| 48 |
33 Criteria for the differential diagnosis between aplastic anemia and hypocellular myelodysplasia
|
Lorand-Metze, I.
|
|
1997
|
21 |
1S1 |
p. S9
|
artikel
|
| 49 |
114 Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure
|
Stafford, DA
|
|
1997
|
21 |
1S1 |
p. S30
|
artikel
|
| 50 |
117 Cytogenetic and molecular study in primary myelodysplastic syndrome
|
de Souza Fernandez, Teresa
|
|
1997
|
21 |
1S1 |
p. S30
|
artikel
|
| 51 |
4 Cytogenetic methods (conventional and FISH) for the study of Myelodysplastic Syndromes
|
Jhanwar, Suresh C.
|
|
1997
|
21 |
1S1 |
p. S1
|
artikel
|
| 52 |
201 Cytogenetics to monitor disease outcome after allo-BMT in patients with myelodysplastic syndrome (MDS)
|
Bernasconi, P.
|
|
1997
|
21 |
1S1 |
p. S53
|
artikel
|
| 53 |
116 Cytogenetic studies in 429 myelodysplastic syndromes:Prognostic value
|
Solé, F.
|
|
1997
|
21 |
1S1 |
p. S30
|
artikel
|
| 54 |
126 Cytogenetic studies in secondary leukemia: Report of 28 cases from one center and comparison with the results in de novo acute myeloid leukemia (AML)
|
Granada, I
|
|
1997
|
21 |
1S1 |
p. S33
|
artikel
|
| 55 |
118 Cytogenetic study and prognostic impact of complex karyotypes in 22 myelodysplastic syndromes
|
Prieto, E.
|
|
1997
|
21 |
1S1 |
p. S31
|
artikel
|
| 56 |
124 Cytogenetic study of 36 patients with secondary myelodysplastic syndrome (MDS)/acute myeloid leukemia(AML)
|
Lun˜o, E.
|
|
1997
|
21 |
1S1 |
p. S32
|
artikel
|
| 57 |
96 Cytokine production in vivo in mds and AML patients
|
Preisler, H.D.
|
|
1997
|
21 |
1S1 |
p. S25
|
artikel
|
| 58 |
26 Cytoplasmic abnormalities of erythroblasts in a patient with refractory anaemia with ring sideroblasts
|
Florensa, L.
|
|
1997
|
21 |
1S1 |
p. S7
|
artikel
|
| 59 |
108 Defective actin polymerization in neutrophils from patients with myelodysplastic syndromes
|
Carulli, G.
|
|
1997
|
21 |
1S1 |
p. S28
|
artikel
|
| 60 |
109 Deficit in integrin expression on PMNs in patients with myelodyslastic syndromes
|
Ricevuti, G.
|
|
1997
|
21 |
1S1 |
p. S28
|
artikel
|
| 61 |
140 Deletion of the pura gene, encoding the single-stranded DNA-binding protein purα, in myelodysplastic syndrome (MDS) and myeloid leukemias
|
Lezon-Geyda, K.A.
|
|
1997
|
21 |
1S1 |
p. S36
|
artikel
|
| 62 |
129 Deletion sq- in a patient with a secondary myelodysplastic syndromes post multiple myeloma
|
Solé, Franceac
|
|
1997
|
21 |
1S1 |
p. S33
|
artikel
|
| 63 |
144 Detection of telomerase activity in cell in myelodysplastic syndromes: Application of in situ telomeric repeat amplification protocol (TRAP)
|
Ohyashiki, K.
|
|
1997
|
21 |
1S1 |
p. S37
|
artikel
|
| 64 |
68 Diagnostic and prognostic significance of elevated percent of fetal hemoglobin containing erythrocytes in patients with myelodysplastic syndromes
|
Śledziowski, P.
|
|
1997
|
21 |
1S1 |
p. S18
|
artikel
|
| 65 |
78 Disturbed interaction between hematopoiesis and bone marrow microenvironment in myelodysplastic syndromes (MDS)
|
Kunert, Ch.
|
|
1997
|
21 |
1S1 |
p. S21
|
artikel
|
| 66 |
105 DNA image cytometry in MDS bone marrow smears
|
Widell, S.
|
|
1997
|
21 |
1S1 |
p. S27
|
artikel
|
| 67 |
27 Does WBC count really define two different subtypes of chronic myelomonocytic leukemia (CMML)? Analysis of a series of 119 patients
|
Cervera, J.
|
|
1997
|
21 |
1S1 |
p. S7
|
artikel
|
| 68 |
131 Duplication of DER(8)t(8:12)(q12:p13) and loss of ETV6 gene in a patient with refractory anaemia
|
Hernández, J.M.
|
|
1997
|
21 |
1S1 |
p. S34
|
artikel
|
| 69 |
187 Effective combined chemotherapy in children with juvenile chronic myelomonocytic leukaemia
|
de Heredia, C. Diaz
|
|
1997
|
21 |
1S1 |
p. S49
|
artikel
|
| 70 |
86 Effects of rHumegakaryocyte growth and development factor (rHuMGDF) on in vitro proliferation of megakaryocyte progenitors in myelodysplastic syndromes (MDS)
|
Fontenay-Roupie, M.
|
|
1997
|
21 |
1S1 |
p. S23
|
artikel
|
| 71 |
87 Effects of three new recombinant. Human GM-CSF/Erythropoietin (EPO) hybrid molecules on in vitro growth of hemopoietic progenitors in myelodysplastic syndromes (MDS)
|
Scalzulli, P.R.
|
|
1997
|
21 |
1S1 |
p. S23
|
artikel
|
| 72 |
74 Enigmatic role(s) of programmed cell death (apoptosis) in myelodysplasias
|
Yoshida, Yataro
|
|
1997
|
21 |
1S1 |
p. S20
|
artikel
|
| 73 |
16 Epidemiology of myelodysplastic syndromes in a French general hospital
|
Bauduer, F.
|
|
1997
|
21 |
1S1 |
p. S5
|
artikel
|
| 74 |
83 Erythropoiesis, erythrokinetics and erytrocytokinetics in myelodysplastic syndromes
|
Lipsic, T.
|
|
1997
|
21 |
1S1 |
p. S22
|
artikel
|
| 75 |
110 Established chromosome changes in myelodysplastic syndromes
|
Van den Berghe, H.
|
|
1997
|
21 |
1S1 |
p. S29
|
artikel
|
| 76 |
97 Expression of CD36 (GPIIIb) on platelets in MDS
|
Neuwirtová, R.
|
|
1997
|
21 |
1S1 |
p. S25
|
artikel
|
| 77 |
104 Expression of CD34, P170, and apoptosis-controlling proteins (BCL-2, BAX, BCL-X, BAD, ICE and CPP32) in myelodysplastic syndromes
|
Campos, L.
|
|
1997
|
21 |
1S1 |
p. S27
|
artikel
|
| 78 |
100 Expression of FAS/APO-1/CD95 antigen and its function in myelodysplastic syndromes
|
Lepelley, P.
|
|
1997
|
21 |
1S1 |
p. S26
|
artikel
|
| 79 |
99 Expression of LRP and its correlation with other drug resistance proteins and outcome in myelodysplastic syndromes (MDS)
|
Lepelley, P.
|
|
1997
|
21 |
1S1 |
p. S26
|
artikel
|
| 80 |
98 Expression of the myeloid antigens on bone marrow cells in patients with myelodisplastic syndromes
|
Masljak, Z.
|
|
1997
|
21 |
1S1 |
p. S26
|
artikel
|
| 81 |
103 Extensive apoptosis of CD34+ marrow cells in patients with mds is related to low colony forming cell number and probably to hematopoietic deficiency
|
Kourakli-Symeonidis, A.
|
|
1997
|
21 |
1S1 |
p. S27
|
artikel
|
| 82 |
22 Familial myelodysplastic syndromes: A key to understanding leukaemogenesis?
|
Mijovic, A.
|
|
1997
|
21 |
1S1 |
p. S6
|
artikel
|
| 83 |
91 Ferrokinetic studies in myelodysplasia suggests a dissociation of proliferation and differentiation in erythropoiesis
|
Brada, S.
|
|
1997
|
21 |
1S1 |
p. S24
|
artikel
|
| 84 |
182 Fludarabine, cytarabine and G-CSF (FLAG) for the treatment of refractory anemia with excess of blasts in transformation (RAEB-t)
|
Ferrara, F.
|
|
1997
|
21 |
1S1 |
p. S48
|
artikel
|
| 85 |
161 G-CSF treatment after intensive chemotherapy in high risk myelodysplastic syndromes (MDS) or acute leukemia (AL) evolving from MDS: A randomized study
|
Bernasconi, C.
|
|
1997
|
21 |
1S1 |
p. S42
|
artikel
|
| 86 |
11 Glutathione S transferase theta 1 (GSTT1) gene defects in myelodysplastic syndromes (MDS) and their correlation with Kryotype and exposure to potential carcinogens
|
Preudhomme, C.
|
|
1997
|
21 |
1S1 |
p. S3
|
artikel
|
| 87 |
60 Hematologic, histologic, cytogenetic, and survival analysis of 60 patients with primary myelodysplastic syndromes (MDS)
|
Souza, J.M.
|
|
1997
|
21 |
1S1 |
p. S16
|
artikel
|
| 88 |
81 Hemopoietic microenvironment in refractory anemia with increased number of blasts (RAEB)
|
Rugal, V.
|
|
1997
|
21 |
1S1 |
p. S21
|
artikel
|
| 89 |
199 Hemopoietic progenitor cells transplantation from HLA-identical siblings for myelodysplasia: Outcome of 11 patients from a single institution
|
Martínez, C.
|
|
1997
|
21 |
1S1 |
p. S53
|
artikel
|
| 90 |
23 Heterogeneity of acquired idiopathic sideroblastic anemia (AISA): Results of a prospective follow-up study in 189 patients
|
Aul, C.
|
|
1997
|
21 |
1S1 |
p. S6
|
artikel
|
| 91 |
139 Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome C oxidase in two patients with acquired idiopathic sideroblastic anaemia
|
Gattermann, N.
|
|
1997
|
21 |
1S1 |
p. S36
|
artikel
|
| 92 |
37 High peripheral but low marrow blasts: Myelodysplastic syndrome or peripheral acute leukemia?
|
Ündar, B.
|
|
1997
|
21 |
1S1 |
p. S10
|
artikel
|
| 93 |
171 Idarubicin, fludarabine, cytarabine and G-CSF (FLAG-IDA) for the treatment of high risk MDS or AML
|
Parker, J.E.
|
|
1997
|
21 |
1S1 |
p. S45
|
artikel
|
| 94 |
85 Identification of a group of thrombocytopenic MDS patients. Candidate for in vivo treatment with PEG-rHuMGDF
|
Fontenay-Roupie, M.
|
|
1997
|
21 |
1S1 |
p. S22
|
artikel
|
| 95 |
73 Immumophenotyping in MDS
|
del Can˜izo, M.C.
|
|
1997
|
21 |
1S1 |
p. S19
|
artikel
|
| 96 |
70 Immunology of MDS, towards a DNA vaccine
|
Hamblin, TJ
|
|
1997
|
21 |
1S1 |
p. S19
|
artikel
|
| 97 |
165 Immunotherapy with low-dose interleukin-2 in patients with myelodysplastic syndromes RAEB and RAEB-T (an ongoing pilot study)
|
Faber, E.
|
|
1997
|
21 |
1S1 |
p. S43
|
artikel
|
| 98 |
59 Impact of advanced age on the prognostic value of karyotype and scoring systems in primary myelodysplastic syndromes (p-MDS)
|
Parlier, V.
|
|
1997
|
21 |
1S1 |
p. S16
|
artikel
|
| 99 |
48 Impact of histopathology on diagnosis, clinics and outcome of myelodysplastic syndromes
|
Georgii, A.
|
|
1997
|
21 |
1S1 |
p. S13
|
artikel
|
| 100 |
20 Incidence of cancer and body iron stores in sideroblastc anemia
|
Sˇisˇková, M.
|
|
1997
|
21 |
1S1 |
p. S6
|
artikel
|
| 101 |
10 Increasing incidence of MDS: Real or fictitious?
|
Aul, C.
|
|
1997
|
21 |
1S1 |
p. S3
|
artikel
|
| 102 |
176 Induction of complete hematological and cytogenic remissions in myelopysplastic syndromes and CMML by topotecan
|
Baran, M
|
|
1997
|
21 |
1S1 |
p. S47
|
artikel
|
| 103 |
189 Infectious complications after intensive remission induction in advanced myelodysplastic syndromes and de novo acute myeloid leukemia
|
Böhme, A.
|
|
1997
|
21 |
1S1 |
p. S50
|
artikel
|
| 104 |
186 Intensive antileukemic treatment and/or allogeneic or autologous bone marrow or PBSC transplantation in myelodysplastic syndromes and in post-MDS acute myeloid leukaemia
|
Finelli, C.
|
|
1997
|
21 |
1S1 |
p. S49
|
artikel
|
| 105 |
174 Intensive chemotherapy (idarubicin, ARA-C, VP-16) combined with G-CSF-priming yields high remission rates in patients with advanced MDS and high-risk AML
|
Ganser, A.
|
|
1997
|
21 |
1S1 |
p. S46
|
artikel
|
| 106 |
184 Intensive chemotherapy in de novo MDS. Outcome of patients who achieved partial remission (PR)
|
Wattel, E.
|
|
1997
|
21 |
1S1 |
p. S49
|
artikel
|
| 107 |
173 Intensive chemotherapy with quinine in myelodysplastic syndromes (MDS)
|
Fenaux, P.
|
|
1997
|
21 |
1S1 |
p. S46
|
artikel
|
| 108 |
153 Interleukin 3 (IL-3) and newer hematopoietic growth factors in the management of myelodysplastic syndrome (MDS)
|
Saba, Hussain I.
|
|
1997
|
21 |
1S1 |
p. S40
|
artikel
|
| 109 |
84 In vitro effect of c-mpl-ligand on CD34 positive cells isolated from patients with chronic myelodysplastic syndromes (MDS)
|
Hofmann, W.-K.
|
|
1997
|
21 |
1S1 |
p. S22
|
artikel
|
| 110 |
133 Karyotype studies in patients with myelodysplastic syndromes
|
Salamantchouk, Z.
|
|
1997
|
21 |
1S1 |
p. S34
|
artikel
|
| 111 |
1 Laboratory presentation and morphological characteristics of myelodysplastic syndromes
|
Vallespí, Teresa
|
|
1997
|
21 |
1S1 |
p. S1
|
artikel
|
| 112 |
156 Lenograstim associated or not to ARA-C (3mg/m2X2) as therapy for poor prognosis refractory anemia with excess of blasts (RAEB)
|
Chomienne, C.
|
|
1997
|
21 |
1S1 |
p. S40
|
artikel
|
| 113 |
63 Leukemic risk im patients aged less than 60 years with myelodysplastic syndromes (MDS): A multivariate analysis of prognostic factors in 140 patients
|
Sanz, G.F.
|
|
1997
|
21 |
1S1 |
p. S17
|
artikel
|
| 114 |
43 Leukemoid reaction mimicking acute promyelocytic leukemia in a patient with myelodysplastic syndrom
|
Carral, A.
|
|
1997
|
21 |
1S1 |
p. S11
|
artikel
|
| 115 |
185 Long term survival after intensive chemotherapy in de novo MDS: Lille's experience
|
Debotton, S.
|
|
1997
|
21 |
1S1 |
p. S49
|
artikel
|
| 116 |
158 Long term treatment of intermediate risk myelodys-plastic syndrome with rhG-CSF and rhEPO: Interim report of an ongoing randomized phase III trial
|
Lentini, G.
|
|
1997
|
21 |
1S1 |
p. S41
|
artikel
|
| 117 |
160 Low-dose Ara-C and G,M-CSF in high-risk myelodysplastic syndromes and acute leukaemia of the old
|
Sastre, JL
|
|
1997
|
21 |
1S1 |
p. S41
|
artikel
|
| 118 |
175 Low dose 5-AZA-′2-deoxycytidine in eldery patients with high risk MDS
|
Wijermans, P.
|
|
1997
|
21 |
1S1 |
p. S46
|
artikel
|
| 119 |
168 Low-dose chemotherapy in MDS
|
Hellström-Lindberg, Eva
|
|
1997
|
21 |
1S1 |
p. S45
|
artikel
|
| 120 |
88 Low stem cell factor plasma levels are correlated with in vitro leukemic growth in myelodysplastic syndromes
|
Cortelezzi, A.
|
|
1997
|
21 |
1S1 |
p. S23
|
artikel
|
| 121 |
106 Mast cell (MC) lineage involvement in myelo-dysplastic syndromes: Diagnostic utility of tryptase staining
|
Valent, P.
|
|
1997
|
21 |
1S1 |
p. S28
|
artikel
|
| 122 |
82 Megakaryopoiesis in myelodysplastic syndromes: Morphological and immunocytochemical features
|
Lorand-Metze, I.
|
|
1997
|
21 |
1S1 |
p. S22
|
artikel
|
| 123 |
203 Molecular biology of elderly AML and its relationship to myelodysplasia (MDS)
|
Willman, Cheryl L.
|
|
1997
|
21 |
1S1 |
p. S55
|
artikel
|
| 124 |
136 Molecular biology of elderly AML and its relationship to myelodysplasia (MDS)
|
Willman, Charyl L
|
|
1997
|
21 |
1S1 |
p. S35
|
artikel
|
| 125 |
141 Molecular definition of two narrow interval at 7q22.1 and 7Q34 associated with myelodysplasia
|
Cotter, F.E.
|
|
1997
|
21 |
1S1 |
p. S36
|
artikel
|
| 126 |
135 Molecular genetics of myeloid disorders characterized by −7/del(7q)
|
Shannon, K.
|
|
1997
|
21 |
1S1 |
p. S35
|
artikel
|
| 127 |
134 Molecular mapping of the DEL(5Q) in myelodysplastic syndromes
|
Le Beau, M.M.
|
|
1997
|
21 |
1S1 |
p. S35
|
artikel
|
| 128 |
113 Morphological, cytogenetic, molecular and etiological features of the ≪ 17p syndrome ≫ in MDS
|
Preudhomme, C.
|
|
1997
|
21 |
1S1 |
p. S29
|
artikel
|
| 129 |
18 Morphological features of myelodysplasia after autologous transplantation
|
Amigo, M.L.
|
|
1997
|
21 |
1S1 |
p. S5
|
artikel
|
| 130 |
62 Multivariate analysis of prognostic factors for survival in 140 patients aged less than 60 years with myelodysplastic syndromes (MDS)
|
Sanz, G.F.
|
|
1997
|
21 |
1S1 |
p. S17
|
artikel
|
| 131 |
138 Mutant RAS or FMS confer abnormal growth in haematopoietic cells: Poor clinical outcome in myelodysplasia with RAS, FMS and p53 mutations
|
Padua, R.A.
|
|
1997
|
21 |
1S1 |
p. S36
|
artikel
|
| 132 |
145 Mutations of the MSH2 gene in myelodysplastic syndrome (MDS)
|
Duthoit, E.
|
|
1997
|
21 |
1S1 |
p. S37
|
artikel
|
| 133 |
57 Myelodisplastic syndromes prognostic factors in 133 patients with cytogenetic study
|
Rus, G. Pérez
|
|
1997
|
21 |
1S1 |
p. S15
|
artikel
|
| 134 |
19 Myelodysplastic syndrome after autologous stem cell transplantation
|
Laurenti, L.
|
|
1997
|
21 |
1S1 |
p. S5
|
artikel
|
| 135 |
147 Myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria; phenotypic and molecular search for an association
|
Iwanaga, M.
|
|
1997
|
21 |
1S1 |
p. S38
|
artikel
|
| 136 |
121 Myelodysplastic syndrome and 17P deletion
|
Stamatoullas, A.
|
|
1997
|
21 |
1S1 |
p. S31
|
artikel
|
| 137 |
39 Myelodysplastic syndrome and thrombotic thrombocytopenic purpura
|
Ündar, L.
|
|
1997
|
21 |
1S1 |
p. S10
|
artikel
|
| 138 |
45 Myelodysplastic syndrome in its fibrotic variant: A borderline to chronic myeloproliferation
|
Wilezak, W.
|
|
1997
|
21 |
1S1 |
p. S12
|
artikel
|
| 139 |
148 Myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) supervening previously untreated chronic B-lymphocytic leukemia (B-cll): Demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis
|
Schwarzmeier, J.D.
|
|
1997
|
21 |
1S1 |
p. S38
|
artikel
|
| 140 |
194 Myelodysplastic syndrome or leukemia developing after MDS treated by allogeneic bone marrow transplantation: Outcome of 90 adult patients
|
Alessandrino, E.P.
|
|
1997
|
21 |
1S1 |
p. S52
|
artikel
|
| 141 |
17 Myelodysplastic syndromes in Thailand: A retrospective pathologic and clinical analysis of 117 cases
|
Intragumtornchai, Tanin
|
|
1997
|
21 |
1S1 |
p. S5
|
artikel
|
| 142 |
64 Myelodysplastic syndromes (MDS) in patients aged>20 and <40 years
|
Latagliata, R.
|
|
1997
|
21 |
1S1 |
p. S17
|
artikel
|
| 143 |
44 Myelodysplastic syndromes with bundles of Auer rods. Study of two cases
|
Domingo-Claros, A
|
|
1997
|
21 |
1S1 |
p. S12
|
artikel
|
| 144 |
123 Neutrophil dysplasia is not a feature of the abnormal chromosomal clones in myelodysplastic syndromes
|
Hast, R.
|
|
1997
|
21 |
1S1 |
p. S32
|
artikel
|
| 145 |
115 New biological insights into chromosome 21 rearrangements in the myelodysplastic syndrome (MDS)
|
Naifeld, V.
|
|
1997
|
21 |
1S1 |
p. S30
|
artikel
|
| 146 |
38 Nodular lesions of monocytic component in myelodysplastic syndrome (MDS)
|
Mongkonsritragoon, W.
|
|
1997
|
21 |
1S1 |
p. S10
|
artikel
|
| 147 |
157 Non-clonal response to erythropoietin in myelodysplastic syndromes
|
Eriksson, M.
|
|
1997
|
21 |
1S1 |
p. S41
|
artikel
|
| 148 |
12 Occupational and environmental exposures and the myelodysplastic syndromes: A case-control study
|
West, RR
|
|
1997
|
21 |
1S1 |
p. S4
|
artikel
|
| 149 |
15 Occupational and environmental risk factors of MDS = a case control study
|
Nisse, C.
|
|
1997
|
21 |
1S1 |
p. S4
|
artikel
|
| 150 |
178 Oral idarubicin administration as monochemotherapy in myelodisplastic syndromes
|
Petrini, M.
|
|
1997
|
21 |
1S1 |
p. S47
|
artikel
|
| 151 |
198 Outcome of bone marrow transplantation in myelodysplastic syndrome or secondary acute myeloid leukemia
|
Lorand-Metze, I
|
|
1997
|
21 |
1S1 |
p. S53
|
artikel
|
| 152 |
146 Oxidative DNA damage and low reduced glutathione concentration is associated with elevated tumor necrosis factor alpha concentration in myelodysplasia
|
Bowen, D.
|
|
1997
|
21 |
1S1 |
p. S38
|
artikel
|
| 153 |
143 Patterns of expression of RAS, P53 and MDM2 proteins in myelodysplastic syndromes
|
Silva, E.S.
|
|
1997
|
21 |
1S1 |
p. S37
|
artikel
|
| 154 |
13 Pediatric myelodysplasia: Characteristics and prognostic factors
|
Ortega, Juao J.
|
|
1997
|
21 |
1S1 |
p. S4
|
artikel
|
| 155 |
80 Phenotypic analysis of endosteal cells in myelodysplastic syndromes and other hemopoietic disorders
|
Sillaber, C.
|
|
1997
|
21 |
1S1 |
p. S21
|
artikel
|
| 156 |
94 Plasma thrombopoietin (TPO) level in patients with myelodysplastic syndromes (MDS)
|
Ogata, K.
|
|
1997
|
21 |
1S1 |
p. S25
|
artikel
|
| 157 |
130 Polysomy for a 20q- chromosome masked by multiple markers in a case of secondary MDS
|
Falzetti, D.
|
|
1997
|
21 |
1S1 |
p. S34
|
artikel
|
| 158 |
162 Potential for use of amifostine in the treatment of poor prognosis acute myelogenous leukemia
|
Preisler, H.D.
|
|
1997
|
21 |
1S1 |
p. S42
|
artikel
|
| 159 |
5 Primary chromosomal abnormalities in myelodysplastic syndromes (MDS)
|
Mecucci, Cristina
|
|
1997
|
21 |
1S1 |
p. S2
|
artikel
|
| 160 |
54 Primary myelodysplastic syndromes : A retrospective study of treatment response and prognostic features in 39 patients in the western region of Algeria
|
Bekadja, M.A
|
|
1997
|
21 |
1S1 |
p. S15
|
artikel
|
| 161 |
52 Primary myelodysplastic syndromes: Multivariate analysis of prognostic factors in Brazilian patients
|
Velloso, E.R.P.
|
|
1997
|
21 |
1S1 |
p. S14
|
artikel
|
| 162 |
14 Problems in the classification of CMML. Dysplastic vs profliferative type
|
Germing, U.
|
|
1997
|
21 |
1S1 |
p. S4
|
artikel
|
| 163 |
55 Prognosis in myelodysplastic syndromes with specific reference to karyotypes — Experience on 296 patients from a single institution
|
Pfeilstöcker, M.
|
|
1997
|
21 |
1S1 |
p. S15
|
artikel
|
| 164 |
47 Prognostic factors in younger patients with myelodysplastic syndromes (MDS)
|
Sanz, G.F.
|
|
1997
|
21 |
1S1 |
p. S13
|
artikel
|
| 165 |
56 Prognostic impact of cytogenetic investigations in 270 patients with primary myelodysplastic syndromes
|
Germing, U.
|
|
1997
|
21 |
1S1 |
p. S15
|
artikel
|
| 166 |
66 Prognostic significance of serum protein electrophoresis pattern changes in patients with myelodysplastic syndromes
|
Symeonidis, A.
|
|
1997
|
21 |
1S1 |
p. S18
|
artikel
|
| 167 |
29 Proliferative chronic myelomonocytic leukemia (P-CMML) emerging after splenectomy in two patients with dysplastic CMML (D-CMML)
|
Vallespí, Teresa
|
|
1997
|
21 |
1S1 |
p. S8
|
artikel
|
| 168 |
164 Promising cyclosporin a therapy for myelodysplastic syndrome
|
Jonásˇová, A.
|
|
1997
|
21 |
1S1 |
p. S42
|
artikel
|
| 169 |
179 Promotion of multilineage hematopoiesis in patients with myelodysplastic syndrome: A phase I/II clinical trial with amifostine
|
List, A.
|
|
1997
|
21 |
1S1 |
p. S47
|
artikel
|
| 170 |
142 5q- Syndrome: Breakpoint investigation
|
Abdelhay, Eliana
|
|
1997
|
21 |
1S1 |
p. S37
|
artikel
|
| 171 |
154 Quality of life in persons with myelodysplastic syndromes: The neglected variable
|
Thomas, Mary Laudon
|
|
1997
|
21 |
1S1 |
p. S40
|
artikel
|
| 172 |
111 Recent and new characteristic chromosome abnormalities in myelodysplastic syndromes (MDS)
|
Mecucci, Cristina
|
|
1997
|
21 |
1S1 |
p. S29
|
artikel
|
| 173 |
46 Recent developments in the prognostic classification for MDS: Results of The International Risk Analysis Workshop
|
Greenberg, P.
|
|
1997
|
21 |
1S1 |
p. S13
|
artikel
|
| 174 |
72 Recruitment and identification of “normal” hematopoietic cells in MDS
|
Frassoni, F
|
|
1997
|
21 |
1S1 |
p. S19
|
artikel
|
| 175 |
25 Refractory anemia, pure sideroblastic anemia and refractory cytopenia with multilineage dysplasia
|
Rus, G. Pérez
|
|
1997
|
21 |
1S1 |
p. S7
|
artikel
|
| 176 |
42 Refractory thrombocytopenia with bone marrow dysplasia: MDS or another entity?
|
Ündar, B.
|
|
1997
|
21 |
1S1 |
p. S11
|
artikel
|
| 177 |
183 Results of treatment in patients with acute myeloid leukemia preceeded by primary myelodysplastic syndrome
|
Urbańska-Ryś, H.
|
|
1997
|
21 |
1S1 |
p. S48
|
artikel
|
| 178 |
32 Review of 100 cases considered like MDS by clinicians
|
Tassin, F.
|
|
1997
|
21 |
1S1 |
p. S9
|
artikel
|
| 179 |
159 r-hu-Epo and G-CSF treatment in simple and sideroblastic refractory anemias: A multicenter study
|
Remacha, A
|
|
1997
|
21 |
1S1 |
p. S41
|
artikel
|
| 180 |
95 Serum levels of thrombopoietin (TPO) In myelodysplasias
|
Fontenay-Roupie, M.
|
|
1997
|
21 |
1S1 |
p. S25
|
artikel
|
| 181 |
128 Single del(11q) in a patient with RAEB which progressed to erythroleukemia
|
Martinez-Climent, J.A.
|
|
1997
|
21 |
1S1 |
p. S33
|
artikel
|
| 182 |
69 Spontaneous improvement of hematological parameters in 8 patients with myelodysplastic syndromes (MDS)
|
Breccia, M.
|
|
1997
|
21 |
1S1 |
p. S18
|
artikel
|
| 183 |
92 Stem cell defect and the genesis of cytopenias in myelodysplastic syndromes (MDS) and their correction by amifostine
|
Raza, A.
|
|
1997
|
21 |
1S1 |
p. S24
|
artikel
|
| 184 |
155 Successful anti-cytokine based approach to treat myelodysplastic syndromes (MDS)
|
Raza, A.
|
|
1997
|
21 |
1S1 |
p. S40
|
artikel
|
| 185 |
53 Survival analysis of 60 patients with primary myelodysplastic syndromes (MDS) according to prognostic groups defined by Mufti (1992)
|
Souza, J.M.
|
|
1997
|
21 |
1S1 |
p. S14
|
artikel
|
| 186 |
65 Survival and outcome in 30 patienta with chronic myelomonocytic leukemia (CMML)
|
Shtarlid, M.
|
|
1997
|
21 |
1S1 |
p. S17
|
artikel
|
| 187 |
41 Sweet's Syndrome in neutropenic patient with myelodysplasia
|
Niero-Melo, L
|
|
1997
|
21 |
1S1 |
p. S11
|
artikel
|
| 188 |
167 Tamoxifen as treatment for myelodysplastic syndromes? — A case report
|
Uhr, M.
|
|
1997
|
21 |
1S1 |
p. S43
|
artikel
|
| 189 |
190 T-cell depleted (SBA-E-) bone marrow transplantation for myelodysplastic syndromes
|
Castro-Malaspina, H.
|
|
1997
|
21 |
1S1 |
p. S51
|
artikel
|
| 190 |
75 Telomere dynamics in myelodysplastic syndromes
|
Toyama, K.
|
|
1997
|
21 |
1S1 |
p. S20
|
artikel
|
| 191 |
76 The absolute number of CD34+ cells and CD34+ cells in S-phase increase during the evolution of myelodysplastic syndromes (MDS)
|
Span, L.
|
|
1997
|
21 |
1S1 |
p. S20
|
artikel
|
| 192 |
93 The combination of all-trans retinoic acid (atra) and bryostatin 1 (BRYO) induces monocytic differentation (MD) In human myeloid leukemia
|
Stone, R.
|
|
1997
|
21 |
1S1 |
p. S24
|
artikel
|
| 193 |
180 The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes
|
Vasilica, M.
|
|
1997
|
21 |
1S1 |
p. S48
|
artikel
|
| 194 |
3 The F.A.B. classification of the myelodysplastic syndromes (MDS)
|
Bennett, J.M.
|
|
1997
|
21 |
1S1 |
p. S1
|
artikel
|
| 195 |
8 The history of MDS: The role of the F.A.B. classification and the development of risk assessment
|
Bennett, John M.
|
|
1997
|
21 |
1S1 |
p. S3
|
artikel
|
| 196 |
49 The influence of cytogenetic abnormalities on treatment outcome after intensive antileukemic therapy for patients with high risk MDS
|
De Witte, T.
|
|
1997
|
21 |
1S1 |
p. S13
|
artikel
|
| 197 |
6 The 5q- syndrome
|
Van den Berghe, H.
|
|
1997
|
21 |
1S1 |
p. S2
|
artikel
|
| 198 |
191 The seattle experience with bone marrow transplantation (BMT) for myelodysplasia (MDS)
|
Anderson, J.E.
|
|
1997
|
21 |
1S1 |
p. S51
|
artikel
|
| 199 |
89 The value of cell cultures for diagnosis of mixed myelodysplastic syndromes/ myelopro-liferative disorders
|
del Can˜izo, M.C.
|
|
1997
|
21 |
1S1 |
p. S23
|
artikel
|
| 200 |
197 t(3;5) High-grade myelodysplasia and acute myeloid leukemia of young adults responds favorably to allogeneic bone marrow transplantation
|
Arber, D.A.
|
|
1997
|
21 |
1S1 |
p. S52
|
artikel
|
| 201 |
67 Thrombocytosis and sideroblastic anaemia
|
Ancin, I.
|
|
1997
|
21 |
1S1 |
p. S18
|
artikel
|
| 202 |
150 Treatment of low-risk MDS: Combination of hematopoietic growth factors and biological response modifiers
|
Hoelzer, D.
|
|
1997
|
21 |
1S1 |
p. S39
|
artikel
|
| 203 |
166 Treatment of multiple transfused patients with myelodysplastic syndromes by iron chelation with desferrioxamine
|
Jensen, P.D.
|
|
1997
|
21 |
1S1 |
p. S43
|
artikel
|
| 204 |
149 Treatment strategies in MDS: Who and how should be treated?
|
Mufti, Ghulam J.
|
|
1997
|
21 |
1S1 |
p. S39
|
artikel
|
| 205 |
204 Trilineage myelodysplasia in patients with acute myeloid leukaemia correlates with shorter disease free and overal survival
|
Staneva, M.
|
|
1997
|
21 |
1S1 |
p. S55
|
artikel
|
Tijdschrift beschrijving